OAM
CELG

Ostrum Asset Management’s Celgene Corp CELG Stock Holding History

Ostrum Asset Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-7,824
Closed -$738K – 152
2019
Q1 		$738K Hold
7,824
– – 0.24% 113
2018
Q4 		$501K Buy
+7,824
New +$578K 0.2% 124

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

Ostrum Asset Management's CELG Position: Q2 2019 in Review

Ostrum Asset Management sold out of Celgene Corp (CELG) in Q2 2019, closing a stake of 7,824 shares — an estimated $738K sold.

Ostrum Asset Management first reported a position in CELG in Q4 2018 and held it in 2 quarters. The position peaked at $738K in Q1 2019. 1,287 funds tracked by Wall St. Rank hold CELG as of Q2 2019.

  • Ostrum Asset Management reported no remaining Celgene Corp position as of Q2 2019 after selling out during the quarter.
  • Ostrum Asset Management sold 7,824 Celgene Corp shares in Q2 2019, an estimated $738K.
  • Ostrum Asset Management first reported a position in Celgene Corp in Q4 2018 and held it in 2 quarters.
  • Ostrum Asset Management's Celgene Corp position peaked at $738K in Q1 2019.
  • 1,287 funds tracked by Wall St. Rank held Celgene Corp as of Q2 2019.

Based on Ostrum Asset Management's 13F filing for Q2 2019, filed 13 Aug 2019.